Your session is about to expire
← Back to Search
Artificial Intelligence
Non-Interventional Centers for Stroke (ALERT Trial)
N/A
Waitlist Available
Led By Jason Tarpley, M.D., Ph. D.
Research Sponsored by Providence Little Company of Mary-Torrance
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time of subject presentation through up to 90 days post treatment.
Awards & highlights
Summary
Post Market, Prospective, Randomized, Controlled, multi center data collection study to evaluate the use of Viz versus the standard of care in stroke workflow and clinical outcome parameters.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ time of subject presentation through up to 90 days post treatment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time of subject presentation through up to 90 days post treatment.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Interventional Centers
Non-Interventional Centers
Secondary outcome measures
Workflow Endpoints
Trial Design
2Treatment groups
Experimental Treatment
Group I: Non-Interventional CentersExperimental Treatment1 Intervention
Cohort A: Viz Subjects Initially Presenting to a Non-Interventional Center The group will be comprised of subjects randomized to Viz and who initially present to a non- interventional center.
Cohort B: Subjects Initially Presenting to a Non-Interventional Center The standard of care group will be comprised of subjects randomized to not have Viz notification and who initially present to a non-interventional center.
Group II: Interventional CentersExperimental Treatment1 Intervention
Cohort C: Viz Subjects Initially Presenting to an Interventional Center The group will be comprised of subjects randomized to Viz and who initially present to a interventional center.
Cohort D: Subjects Initially Presenting to a Interventional Center The standard of group will be comprised of subjects randomized to not have Viz notification and who initially present to an interventional center.
Find a Location
Who is running the clinical trial?
Viz.ai, Inc.Industry Sponsor
3 Previous Clinical Trials
6,500 Total Patients Enrolled
Providence Little Company of Mary-TorranceLead Sponsor
Jason Tarpley, M.D., Ph. D.Principal InvestigatorProvidence Little Company of Mary Medical Center-Torrance
Share this study with friends
Copy Link
Messenger